e-learning
resources
Paris 2018
Tuesday, 18.09.2018
CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact Prognostic impact of comorbidities in patients with chronic Hypersensitivity Pneumonitis
J. Wälscher (Heidelberg, Germany), B. Gross (Heidelberg, Germany), J. Bruhwyler (Gembloux, Belgium), J. Morisset (Quebec, Canada), C. Heussel (Heidelberg, Germany), F. Lasitschka (Heidelberg, Germany), F. Herth (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany)
Source:
International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session:
CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session type:
Poster Discussion
Number:
3669
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Wälscher (Heidelberg, Germany), B. Gross (Heidelberg, Germany), J. Bruhwyler (Gembloux, Belgium), J. Morisset (Quebec, Canada), C. Heussel (Heidelberg, Germany), F. Lasitschka (Heidelberg, Germany), F. Herth (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany). Impact Prognostic impact of comorbidities in patients with chronic Hypersensitivity Pneumonitis. 3669
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Chronic Hypersensitivity Pneumonitis and mortality: impact of comorbidities
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020
Prognostic factors in Korean patients with chronic hypersensitivity pneumonitis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Prognostic characteristics in chronic hypersensitivity pneumonitis.
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Prognostic factors in chronic hypersensitivity pneumonitis
Source: Eur Respir Rev, 29 (156) 190167; 10.1183/16000617.0167-2019
Year: 2020
Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Recurrent exacerbation of asthma: Characteristics of the patients and risk factors
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Acute exacerbation in patients with bronchiectasis: What prognostic factors?
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Impact of concomitant cardiovascular diseases on functional status and quality of life of patients with Chronic Obstructive Pulmonary Diseases
Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation
Year: 2019
Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Determinants and assessment of excess cardiovascular risk in bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Episodes of Acute Respiratory Deterioration in patients with idiopathic pulmonary fibrosis in the UK – mortality and contributing factors
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
Prognostic impact and clinical characteristics of Interstitial Pneumonia with Autoimmune features (IPAF) in a multidisciplinary setting
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Mortality and survival predictor in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Disease behaviour and prognostic factors in Hypersensitivity Pneumonitis with UIP-like pattern
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021
Effect of systemic inflammation and multi-morbidity on outcome of adult-onset asthma
Source: International Congress 2016 – Asthma management
Year: 2016
Impact of Sarcopenia and Malnutrition on disease severity, nutritional variables and inflammatory parameters in COPD patients
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019
Predictive factors for readmission of patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Prognostic significance of Glasgow Prognostic Score in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Comorbidities in chronic obstructive pulmonary disease: Prognostic factors?
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept